CIK: 0001595851 · Show all filings
Period: Q2 2024 (← Previous) (Next →)
Filing Date: Aug 14, 2024
Total Value: $319M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| BHVN | BIOHAVEN LTD | 490,000 | $17.01M | 5.3% | $35.01 | +12.9% | COM | G1110E107 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 68,400 | $16.62M | 5.2% | $168.43 | -6.3% | Put | 02043Q107 |
| INSM | INSMED INC | 200,000 | $13.4M | 4.2% | $27.99 | +38.6% | Call | 457669307 |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 300,000 | $13.19M | 4.1% | $45.36 | -6.6% | CLASS A ORD | 61559X104 |
| SLNO | SOLENO THERAPEUTICS INC | 300,000 | $12.24M | 3.8% | $37.99 | +11.5% | COM | 834203309 |
| AXSM | AXSOME THERAPEUTICS INC | 150,000 | $12.07M | 3.8% | $54.36 | +36.2% | COM | 05464T104 |
| ASND | ASCENDIS PHARMA A/S | 86,721 | $11.83M | 3.7% | $136.38 | — | SPONSORED ADR | 04351P101 |
| PCVX | VAXCYTE INC | 150,000 | $11.33M | 3.5% | $51.35 | +32.6% | COM | 92243G108 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 240,000 | $10.75M | 3.4% | $35.29 | +30.9% | COM | 22663K107 |
| ROIV | ROIVANT SCIENCES LTD | 1,000,000 | $10.57M | 3.3% | $10.26 | +6.8% | SHS | G76279101 |
| CATX | PERSPECTIVE THERAPEUTICS INC | 925,000 | $9.222M | 2.9% | $14.46 | 0.0% | COM NEW | 46489V302 |
| TGTX | TG THERAPEUTICS INC | 500,000 | $8.895M | 2.8% | $15.64 | +2.0% | COM | 88322Q108 |
| SRPT | SAREPTA THERAPEUTICS INC | 55,000 | $8.69M | 2.7% | $101.29 | +26.8% | COM | 803607100 |
| CGON | CG ONCOLOGY INC | 260,000 | $8.208M | 2.6% | $36.44 | -4.9% | COM | 156944100 |
| CRBP | CORBUS PHARMACEUTICALS HLDGS | 175,000 | $7.919M | 2.5% | $36.40 | +15.6% | COM NEW | 21833P301 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 587,708 | $7.646M | 2.4% | $19.55 | -29.2% | COM | 92790C104 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 350,000 | $7.186M | 2.3% | $21.52 | -2.7% | COM | 87164F105 |
| IMVT | IMMUNOVANT INC | 260,000 | $6.864M | 2.1% | $32.31 | -12.0% | COM | 45258J102 |
| TARS | TARSUS PHARMACEUTICALS INC | 235,000 | $6.387M | 2.0% | $20.09 | +67.4% | COM | 87650L103 |
| PHAT | PHATHOM PHARMACEUTICALS INC | 600,000 | $6.18M | 1.9% | $11.64 | -11.6% | COM | 71722W107 |
| RZLT | REZOLUTE INC | 1,421,501 | $6.112M | 1.9% | $3.44 | 0.0% | COM NEW | 76200L309 |
| OLMA | OLEMA PHARMACEUTICALS INC | 550,000 | $5.951M | 1.9% | $11.59 | -6.5% | COM | 68062P106 |
| SYRE | SPYRE THERAPEUTICS INC | 250,237 | $5.883M | 1.8% | $31.83 | +6.0% | COM NEW | 00773J202 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 22,500 | $5.468M | 1.7% | $168.43 | -6.3% | COM | 02043Q107 |
| APLS | APELLIS PHARMACEUTICALS INC | 135,000 | $5.179M | 1.6% | $63.06 | -28.2% | COM | 03753U106 |
| VKTX | VIKING THERAPEUTICS INC | 95,000 | $5.036M | 1.6% | $49.37 | +32.8% | COM | 92686J106 |
| RYTM | RHYTHM PHARMACEUTICALS INC | 117,388 | $4.82M | 1.5% | $43.76 | -8.8% | COM | 76243J105 |
| INSM | INSMED INC | 65,000 | $4.355M | 1.4% | $27.99 | +38.6% | COM PAR $.01 | 457669307 |
| — | BLUEPRINT MEDICINES CORP | 40,000 | $4.311M | 1.4% | $94.86 | — | COM | 09627Y109 |
| SVRA | SAVARA INC | 1,050,876 | $4.235M | 1.3% | $4.36 | +2.0% | COM | 805111101 |
| TNYA | TENAYA THERAPEUTICS INC | 1,350,000 | $4.185M | 1.3% | $4.51 | -8.3% | COM | 87990A106 |
| REPL | REPLIMUNE GROUP INC | 450,000 | $4.05M | 1.3% | $10.29 | -32.3% | COM | 76029N106 |
| ENGN | ENGENE HOLDINGS INC | 420,331 | $3.964M | 1.2% | $12.55 | +2.2% | COM | 29286M105 |
| ACAD | ACADIA PHARMACEUTICALS INC | 225,000 | $3.656M | 1.1% | $25.31 | -36.2% | COM | 004225108 |
| BBIO | BRIDGEBIO PHARMA INC | 140,000 | $3.546M | 1.1% | $26.78 | +2.1% | COM | 10806X102 |
| KRRO | KORRO BIO INC | 100,000 | $3.387M | 1.1% | $55.25 | 0.0% | COM | 500946108 |
| NUVB | NUVATION BIO INC | 1,150,000 | $3.358M | 1.1% | $3.05 | 0.0% | COM CL A | 67080N101 |
| BBOT | HELIX ACQUISITION CORP II | 300,000 | $3.066M | 1.0% | $10.35 | -0.6% | CL A ORD SHS | G4444H101 |
| TSHA | TAYSHA GENE THERAPIES INC | 1,250,000 | $2.8M | 0.9% | $2.15 | +35.1% | COM SHS | 877619106 |
| CABA | CABALETTA BIO INC | 370,899 | $2.774M | 0.9% | $19.60 | -37.5% | COM | 12674W109 |
| NGNE | NEUROGENE INC | 70,000 | $2.547M | 0.8% | $34.60 | +1.9% | COM | 64135M105 |
| JANX | JANUX THERAPEUTICS INC | 50,000 | $2.095M | 0.7% | $46.95 | 0.0% | COM | 47103J105 |
| ARVN | ARVINAS INC | 75,000 | $1.996M | 0.6% | $27.34 | +16.6% | COM | 04335A105 |
| RGNX | REGENXBIO INC | 170,000 | $1.989M | 0.6% | $17.14 | -9.2% | COM | 75901B107 |
| CYTK | CYTOKINETICS INC | 33,200 | $1.799M | 0.6% | $57.33 | +5.3% | COM NEW | 23282W605 |
| — | ELEVATION ONCOLOGY INC | 600,000 | $1.62M | 0.5% | $3.71 | — | COM | 28623U101 |
| KRYS | KRYSTAL BIOTECH INC | 8,500 | $1.561M | 0.5% | $117.03 | +43.5% | COM | 501147102 |
| ANNX | ANNEXON INC | 310,000 | $1.519M | 0.5% | $5.17 | 0.0% | COM | 03589W102 |
| PRQR | PROQR THRAPEUTICS N V | 900,000 | $1.494M | 0.5% | $1.94 | 0.0% | SHS EURO | N71542109 |
| ATYR | ATYR PHARMA INC | 800,000 | $1.248M | 0.4% | $1.74 | -0.2% | COM NEW | 002120202 |
| ANNX | ANNEXON INC | 214,500 | $1.051M | 0.3% | $5.17 | 0.0% | Call | 03589W102 |
| WVE | WAVE LIFE SCIENCES LTD | 200,000 | $998K | 0.3% | $5.70 | 0.0% | SHS | Y95308105 |
| — | RAPT THERAPEUTICS INC | 300,000 | $915K | 0.3% | — | — | Call | 75382E109 |
| ARWR | ARROWHEAD PHARMACEUTICALS IN | 35,000 | $910K | 0.3% | $31.99 | -23.2% | COM | 04280A100 |
| SGMT | SAGIMET BIOSCIENCES INC | 225,000 | $770K | 0.2% | $7.18 | -36.1% | COM SER A | 786700104 |
| — | INTRA-CELLULAR THERAPIES INC | 10,000 | $685K | 0.2% | $68.49 | — | COM | 46116X101 |
| MGNX | MACROGENICS INC | 150,000 | $638K | 0.2% | $9.74 | 0.0% | COM | 556099109 |
| PMVP | PMV PHARMACEUTICALS INC | 375,000 | $608K | 0.2% | $6.13 | -70.6% | COM | 69353Y103 |
| PTCT | PTC THERAPEUTICS INC | 19,000 | $581K | 0.2% | $32.39 | 0.0% | COM | 69366J200 |
| — | REVANCE THERAPEUTICS INC | 225,000 | $578K | 0.2% | $21.62 | — | COM | 761330109 |
| NTLA | INTELLIA THERAPEUTICS INC | 25,000 | $560K | 0.2% | $27.78 | -14.3% | COM | 45826J105 |
| ANTX | AN2 THERAPEUTICS INC | 219,331 | $472K | 0.1% | $10.88 | -78.1% | COM | 037326105 |
| CTMX | CYTOMX THERAPEUTICS INC | 300,000 | $366K | 0.1% | $1.85 | +7.8% | COM | 23284F105 |